Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Integra Lifesciences Holdings (IART) Inventory Average (2016 - 2026)

Integra Lifesciences Holdings' Inventory Average history spans 16 years, with the latest figure at $490.9 million for Q4 2025.

  • On a quarterly basis, Inventory Average rose 13.37% to $490.9 million in Q4 2025 year-over-year; TTM through Dec 2025 was $490.9 million, a 13.37% increase, with the full-year FY2025 number at $460.9 million, up 12.6% from a year prior.
  • Inventory Average hit $490.9 million in Q4 2025 for Integra Lifesciences Holdings, up from $477.1 million in the prior quarter.
  • Over the last five years, Inventory Average for IART hit a ceiling of $490.9 million in Q4 2025 and a floor of $315.6 million in Q3 2022.
  • Historically, Inventory Average has averaged $376.7 million across 5 years, with a median of $356.5 million in 2023.
  • Biggest five-year swings in Inventory Average: fell 6.48% in 2021 and later rose 19.17% in 2024.
  • Tracing IART's Inventory Average over 5 years: stood at $322.3 million in 2021, then dropped by 1.38% to $317.8 million in 2022, then rose by 18.91% to $377.9 million in 2023, then grew by 14.57% to $433.0 million in 2024, then grew by 13.37% to $490.9 million in 2025.
  • Business Quant data shows Inventory Average for IART at $490.9 million in Q4 2025, $477.1 million in Q3 2025, and $455.3 million in Q2 2025.